Table 3.
Trends in invasive procedures for patients hospitalized from 2004 to 2019.
| Type of Procedure | Overall | 2004–2005 | 2005–2006 | 2006–2007 | 2007–2008 | 2008–2009 | 2009–2010 | 2010–2011 | 2011–2012 | 2012–2013 | 2013–2014 | 2014–2015 | 2015–2016 | 2016–2017 | 2017–2018 | 2018–2019 |
p-Value (Trend) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Admissions, n |
825 | 38 | 48 | 48 | 53 | 57 | 60 | 55 | 60 | 65 | 67 | 58 | 50 | 51 | 55 | 60 | |
| Procedure, n (%) |
207 (25.1) |
11 (28.9) |
14 (29.2) |
13 (27.1) |
15 (28.3) |
16 (28.1) |
17 (28.3) |
15 (27.3) |
16 (26.7) |
16 (24.6) |
16 (23.9) |
13 (22.4) |
11 (22) |
11 (21.6) |
11 (20) |
12 (20) |
<0.0001 |
| Liver biopsy | 132 (63.8) |
6 (54.5) |
6 (42.9) |
8 (61.5) |
8 (53.3) |
9 (56.3) |
9 (52.9) |
10 (66.7) |
11 (68.8) |
12 (75.0) |
11 (68.8) |
9 (69.2) |
9 (81.8) |
7 (63.6) |
8 (72.7) |
9 (75.0) |
0.0004 |
| Pancreatic biopsy | 17 (8.2) |
2 (18.2) |
2 (14.3) |
2 (15.4) |
3 (20) |
3 (18.8) |
2 (11.8) |
1 (6.7) |
1 (6.3) |
1 (6.3) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
<0.0001 |
| Lung/pleural biopsy | 12 (5.8) |
1 (9.1) |
2 (14.3) |
1 (7.7) |
1 (6.7) |
2 (12.5) |
2 (11.8) |
1 (6.7) |
1 (6.3) |
0 (0) |
1 (6.3) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
<0.0001 |
| Bone biopsy | 5 (2.4) |
1 (9.1) |
1 (7.1) |
0 (0) |
1 (6.7) |
1 (6.3) |
1 (5.9) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0.0013 |
| ERCP | 33 (15.9) |
1 (9.1) |
2 (14.3) |
1 (7.7) |
2 (13.3) |
1 (6.3) |
2 (11.8) |
2 (13.3) |
3 (18.8) |
2 (12.5) |
4 (25.0) |
3 (23.1) |
2 (18.2) |
3 (27.3) |
3 (27.3) |
2 (16.7) |
0.0231 |
| Other * | 8 (3.9) |
0 (0) |
1 (7.1) |
1 (7.7) |
0 (0) |
0 (0) |
1 (5.9) |
1 (6.7) |
0 (0) |
1 (6.3) |
0 (0) |
1 (7.7) |
0 (0) |
1 (9.1) |
0 (0) |
1 (8.3) |
0.1213 |
* Arteriography and diagnostic and/or therapeutic surgical procedures including laparoscopy and pleuroscopy. ERCP, endoscopic retrograde cholangiopancreatography.